Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Improving Outcomes in Early Menopause After Cancer

for
Early Menopause, Cancer, Premature Menopause,
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 18 - 44

Code: NCT06982677

Recruiting

Video Inspired Discussions About Ethical Outcomes in Pediatrics

for
Pediatric Cancer
Location: Boston MA, Atlanta GA, Birmingham AL
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0+

Code: NCT06786104

Recruiting

Study of FID-022 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Tampa FL, Duarte CA, Los Angeles CA
Sponsor: Fulgent Pharma LLC.

Sex: All

Age: 18+

Code: NCT06694480

Phase 1, Recruiting

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

for
Medulloblastoma, Central Nervous System Embryonal Tumor,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 1 - 30

Code: NCT07087002

Phase 1, Recruiting

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Bishop CA, Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 0+

Code: NCT07332312

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

for
Head and Neck Squamous Cell Carcinoma,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07172256

Phase 2, Recruiting

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

for
Mobile Applications, Cancer Patients
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT06860425

Recruiting

Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

for
Cancer
Location: Saint John, Quebec, Sherbrooke, Ottawa, Kingston,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT07390435

Recruiting

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

for
Cancer, Frail, Chemotherapy
Location: Winston-Salem NC, Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 65+

Code: NCT07175376

Recruiting

Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy

for
Colorectal (Colon or Rectal) Cancer, Pelvic Malignancies,
Location: Tampa FL
Sponsor: University of South Florida

Sex: Female

Age: 1 - 3

Code: NCT07419490

Recruiting

100-Year Human Aging Study

for
Aging, Aging Well, All-Cause Mortality, Mortality,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07563777

Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for
Neoplasms, Colorectal, Neoplasms
Location: Toronto, Montreal, Hamilton, Canton OH, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07213609

Phase 1, Phase 2, Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Boston MA, Montreal, Philadelphia PA, Fairfax VA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase 1, Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

for
Advanced Solid Tumor
Location: Boston MA, Hartford CT, New Haven CT, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07070232

Phase 1, Phase 2, Recruiting

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for
Endometrial Cancer, Malignant Solid Tumour
Location: Scarborough ME, Stony Brook NY, White Plains NY,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07044336

Phase 3, Recruiting

Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers

for
Cancer
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 70+

Code: NCT06927050

Recruiting

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT07030283

Phase 1, Recruiting

Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma

for
Pancreatic Ductal Adenocarcinoma
Location: Bay Shore NY, New Hyde Park NY, Mount Kisco NY,
Sponsor: Northwell Health

Sex: All

Age: 18+

Code: NCT07163273

Phase 2, Recruiting

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

for
Solid Tumors, Sarcomas
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07374848

Phase 1, Recruiting

Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07216534

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial